These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chelating agents in the prevention and treatment of occupational diseases. BRIEGER H Arch Environ Health; 1960 Sep; 1():271-7. PubMed ID: 13804399 [No Abstract] [Full Text] [Related]
3. [Introductory recollections on cellular and extracellular ionic balance, and changes brought about by chelating substances; preliminary notes on the use and the indications of said substances in cardiovascular pathology]. MACCARINI PA Clin Ter; 1962 Jan; 22():126-32. PubMed ID: 14467754 [No Abstract] [Full Text] [Related]
4. [Oral use of chelating agents in the treatment and prevention of lead poisoning]. TOLOT F; JAQUIS ; GENEVOIS M; SOUBRIER R; BRESSON JR Arch Mal Prof; 1962 Jun; 23():376-9. PubMed ID: 13921666 [No Abstract] [Full Text] [Related]
5. [The therapeutic possibilities of various chelating substances in radiation sickness]. GALLI G Minerva Fisioter Radiobiol; 1959; 4():322-7. PubMed ID: 13826127 [No Abstract] [Full Text] [Related]
6. [Observations on the use of sodium diethyldithiocarbamate in therapy]. PARMEGGIANI L; PALLENI R Med Lav; 1961 May; 52():377-81. PubMed ID: 14483977 [No Abstract] [Full Text] [Related]
7. Design of chelates for therapeutic objectives. RUBIN M Fed Proc; 1961 Sep; 20(3)Pt 2():149-56. PubMed ID: 14494918 [No Abstract] [Full Text] [Related]
10. [Therapy of hemochromatosis]. WOEHLER F Med Klin; 1962 Aug; 57():1370-6. PubMed ID: 14007830 [No Abstract] [Full Text] [Related]
11. [On the therapeutic efficacy in hypochromic anemia of a preparation with iron chelate base. Our clinical experience on 50 cases]. DAL MONTE PR Gazz Med Ital; 1960 Nov; 119():470-5. PubMed ID: 13719388 [No Abstract] [Full Text] [Related]
12. Evaluation of trisodium calcium diethylenetriaminepentacetate in iron storage disease. FAHEY JL; RATH CE; PRINCIOTTO JV; BRICK IB; RUBIN M J Lab Clin Med; 1961 Mar; 57():436-49. PubMed ID: 13697901 [No Abstract] [Full Text] [Related]
13. Potential uses of chelation methods in the treatment of cardiovascular diseases. KITCHELL JR; MELTZER LE; SEVEN MJ Prog Cardiovasc Dis; 1961 Jan; 3():338-49. PubMed ID: 13756462 [No Abstract] [Full Text] [Related]
14. Removal of internally deposited radionuclides by triethylenetetraamine-hexaacetic acid. CATSCH A; SCHINDEWOLF-JORDAN D Nature; 1961 Aug; 191():715. PubMed ID: 13691586 [No Abstract] [Full Text] [Related]
15. [Use of complexons in medicine]. ELBOWICZ-WANIEWSKA Z Pol Tyg Lek; 1961 Apr; 16():646-50. PubMed ID: 13726313 [No Abstract] [Full Text] [Related]
16. 2 cases of scleroderma treated by chelators. DEPONDT M; FLAMANT R; ROY L Gaz Med Fr; 1961 Feb; 68():459-62. PubMed ID: 13721997 [No Abstract] [Full Text] [Related]
17. [Metabolism of iron and copper, action of chelators and therapeutic possibilities in Wilson's disease and hemochromatosis]. PIRART J Pathol Biol; 1961 May; 9():1157-74. PubMed ID: 13735975 [No Abstract] [Full Text] [Related]
18. [Preliminary note on the therapeutic use of flavonic magnesium chelates in mental disorders of senescence. Pharmacodynamic and experimental data]. BERNARD P; NOEL P; BLES G Rev Fr Gerontol; 1962 Apr; 8():179-82. PubMed ID: 13868049 [No Abstract] [Full Text] [Related]